% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Velimirovic:301746,
author = {M. Velimirovic$^*$ and A. Avenhaus$^*$ and C. Lohrey$^*$
and J. Bulkescher$^*$ and F. Hoppe-Seyler$^*$ and K.
Hoppe-Seyler$^*$},
title = {{H}ypoxic {HPV}-{P}ositive {C}ancer {C}ells {A}re
{P}articularly {S}ensitive to the {P}ro-{S}enescent
{E}ffects of {B}-{MYB} {R}epression {D}ue to the {L}ack of
{C}ompensatory {A}-{MYB} {I}nduction.},
journal = {Journal of medical virology},
volume = {97},
number = {6},
issn = {0146-6615},
address = {Bognor Regis [u.a.]},
publisher = {Wiley},
reportid = {DKFZ-2025-01130},
pages = {e70422},
year = {2025},
note = {#EA:D365#LA:D365#},
abstract = {Tumor hypoxia is typically linked to increased therapy
resistance and poor prognosis of many malignancies,
including HPV-positive cancers. One possible resistance
mechanism is the increased resistance of hypoxic tumor cells
to cellular senescence. It is thus highly interesting to
identify strategies which could increase their pro-senescent
susceptibility. In comparative analyses of normoxic and
hypoxic HPV-positive cancer cells, we here uncover that the
interconnection between B-MYB and its paralog A-MYB plays a
key role for their senescence response, but shows a
differential regulation under normoxia and hypoxia. In
specific, we demonstrate that the pro-senescent response to
B-MYB loss is counteracted by a compensatory upregulation of
A-MYB under normoxia. Therefore, efficient induction of
senescence in normoxic cells requires the downregulation of
both B-MYB and A-MYB. Interestingly, this compensatory A-MYB
induction is absent under hypoxia, rendering hypoxic cancer
cells particularly sensitive to the pro-senescent effect of
B-MYB repression. We further show that these regulatory
effects are not confined to HPV-positive cancer cells,
indicating that they could be broadly conserved between
different cancer types. Collectively, our findings reveal
that hypoxic cancer cells are particularly sensitive to
B-MYB inhibition, which could provide a new strategy to
target this therapeutically challenging cancer cell
population.},
keywords = {Humans / Cellular Senescence / Cell Line, Tumor /
Trans-Activators: genetics / Trans-Activators: metabolism /
Cell Hypoxia / Papillomaviridae / Papillomavirus Infections
/ Cell Cycle Proteins / Proto-Oncogene Proteins c-myb /
A‐MYB (Other) / B‐MYB (Other) / cervical cancer (Other)
/ human papillomavirus (HPV) (Other) / hypoxia (Other) /
senescence (Other) / Trans-Activators (NLM Chemicals) /
MYBL2 protein, human (NLM Chemicals) / MYB protein, human
(NLM Chemicals) / Cell Cycle Proteins (NLM Chemicals) /
Proto-Oncogene Proteins c-myb (NLM Chemicals)},
cin = {D365},
ddc = {610},
cid = {I:(DE-He78)D365-20160331},
pnm = {314 - Immunologie und Krebs (POF4-314)},
pid = {G:(DE-HGF)POF4-314},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40444458},
pmc = {pmc:PMC12123558},
doi = {10.1002/jmv.70422},
url = {https://inrepo02.dkfz.de/record/301746},
}